ArticleDermatology reports2026

Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after checkpoint inhibitor treatment: a case report.

Carlotta Bertolina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.